EX-99.3 4 d300155dex993.htm EX-99.3

Exhibit 99.3

ASX/Media Release (Code: ASX: PRR; NASDAQ: PBMD)

25 November 2016

RESULTS OF MEETING

SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima”, the “Company”) is pleased to advise that the four resolutions contained within the Notice of Meeting were put to shareholders today at PRR’s Annual General Meeting.

All resolutions were carried unanimously. The proxies received in respect of each resolution are as follows.

No. |  | Resolution |  | Votes Method - show of hands (S) or poll (P) |  | For |  |  | Against |  |  | Abstain |  |  | Open |
1 |  | Adoption of the Remuneration Report |  | S |  |  | 124,693,786 |  |  |  | 22,547,621 |  |  |  | 6,236,461 |  |  |  | 10,757,225 |
2 |  | Re-election of Director – Dr Russell Howard |  | S |  |  | 199,938,776 |  |  |  | 10,710,647 |  |  |  | 3,166,895 |  |  |  | 9,820,124 |
3 |  | Grant of Director Performance Rights to Mr Pete Meyers |  | S |  |  | 133,006,055 |  |  |  | 62,098,183 |  |  |  | 12,121,895 |  |  |  | 9,547,565 |
4 |  | Approval of 10% Placement Facility |  | S |  |  | 137,760,271 |  |  |  | 71,513,494 |  |  |  | 3,490,860 |  |  |  | 10,871,817 |

On behalf of the Board of Prima.

/s/ Tom Bloomfield

Tom Bloomfield

Company Secretary